科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/02/17 | 5,940 | 5,960 | 5,890 | 5,950 | -70 | -1.2% | 56,900 |
2020/02/14 | 5,910 | 6,040 | 5,900 | 6,020 | +80 | +1.3% | 82,800 |
2020/02/13 | 5,990 | 5,990 | 5,890 | 5,940 | ±0 | ±0% | 68,000 |
2020/02/12 | 6,070 | 6,070 | 5,880 | 5,940 | -110 | -1.8% | 102,300 |
2020/02/10 | 6,070 | 6,110 | 6,040 | 6,050 | -90 | -1.5% | 43,100 |
2020/02/07 | 6,130 | 6,200 | 6,110 | 6,140 | +30 | +0.5% | 151,600 |
2020/02/06 | 6,050 | 6,170 | 6,050 | 6,110 | +160 | +2.7% | 155,700 |
2020/02/05 | 5,900 | 5,990 | 5,860 | 5,950 | +70 | +1.2% | 98,600 |
2020/02/04 | 5,940 | 5,950 | 5,850 | 5,880 | -50 | -0.8% | 108,500 |
2020/02/03 | 5,770 | 6,050 | 5,770 | 5,930 | +110 | +1.9% | 269,100 |
2020/01/31 | 5,810 | 5,880 | 5,790 | 5,820 | +80 | +1.4% | 91,700 |
2020/01/30 | 5,850 | 5,870 | 5,710 | 5,740 | -160 | -2.7% | 74,400 |
2020/01/29 | 5,880 | 5,910 | 5,830 | 5,900 | +40 | +0.7% | 73,400 |
2020/01/28 | 5,830 | 5,870 | 5,780 | 5,860 | +10 | +0.2% | 97,600 |
2020/01/27 | 5,840 | 5,870 | 5,780 | 5,850 | -90 | -1.5% | 112,400 |
2020/01/24 | 5,990 | 5,990 | 5,880 | 5,940 | -10 | -0.2% | 68,700 |
2020/01/23 | 6,020 | 6,040 | 5,930 | 5,950 | -150 | -2.5% | 78,900 |
2020/01/22 | 6,060 | 6,120 | 6,060 | 6,100 | +10 | +0.2% | 91,200 |
2020/01/21 | 6,080 | 6,120 | 6,070 | 6,090 | ±0 | ±0% | 59,500 |
2020/01/20 | 6,090 | 6,110 | 6,050 | 6,090 | +20 | +0.3% | 80,900 |
2020/01/17 | 6,010 | 6,080 | 6,000 | 6,070 | +100 | +1.7% | 110,600 |
2020/01/16 | 5,990 | 5,990 | 5,910 | 5,970 | +30 | +0.5% | 82,700 |
2020/01/15 | 5,980 | 6,010 | 5,900 | 5,940 | -40 | -0.7% | 97,000 |
2020/01/14 | 5,980 | 6,010 | 5,940 | 5,980 | -60 | -1% | 88,600 |
2020/01/10 | 6,000 | 6,060 | 6,000 | 6,040 | +50 | +0.8% | 67,000 |
2020/01/09 | 5,950 | 6,020 | 5,920 | 5,990 | +120 | +2% | 73,600 |
2020/01/08 | 5,880 | 5,930 | 5,850 | 5,870 | -80 | -1.3% | 77,700 |
2020/01/07 | 5,890 | 5,960 | 5,880 | 5,950 | +30 | +0.5% | 95,000 |
2020/01/06 | 5,850 | 5,980 | 5,830 | 5,920 | -120 | -2% | 100,200 |
2019/12/30 | 5,970 | 6,060 | 5,950 | 6,040 | -30 | -0.5% | 59,900 |
2019/12/27 | 6,070 | 6,100 | 6,060 | 6,070 | -10 | -0.2% | 42,400 |
2019/12/26 | 6,010 | 6,080 | 6,000 | 6,080 | +70 | +1.2% | 53,500 |
2019/12/25 | 6,060 | 6,060 | 5,990 | 6,010 | -30 | -0.5% | 36,500 |
2019/12/24 | 6,070 | 6,080 | 6,000 | 6,040 | +10 | +0.2% | 49,600 |
2019/12/23 | 6,080 | 6,080 | 6,000 | 6,030 | -70 | -1.1% | 44,400 |
2019/12/20 | 6,160 | 6,160 | 6,050 | 6,100 | -50 | -0.8% | 80,000 |
2019/12/19 | 6,110 | 6,180 | 6,110 | 6,150 | +40 | +0.7% | 70,900 |
2019/12/18 | 6,100 | 6,110 | 6,050 | 6,110 | -10 | -0.2% | 97,900 |
2019/12/17 | 6,100 | 6,130 | 6,060 | 6,120 | +40 | +0.7% | 74,600 |
2019/12/16 | 6,040 | 6,150 | 6,030 | 6,080 | +50 | +0.8% | 100,800 |
2019/12/13 | 6,030 | 6,110 | 6,020 | 6,030 | +100 | +1.7% | 183,900 |
2019/12/12 | 5,960 | 5,980 | 5,910 | 5,930 | -40 | -0.7% | 72,900 |
2019/12/11 | 6,000 | 6,040 | 5,960 | 5,970 | -30 | -0.5% | 59,000 |
2019/12/10 | 6,010 | 6,020 | 5,960 | 6,000 | -10 | -0.2% | 87,700 |
2019/12/09 | 6,000 | 6,020 | 5,970 | 6,010 | +40 | +0.7% | 62,100 |
2019/12/06 | 5,940 | 5,990 | 5,930 | 5,970 | -10 | -0.2% | 56,100 |
2019/12/05 | 5,970 | 5,980 | 5,920 | 5,980 | +40 | +0.7% | 80,800 |
2019/12/04 | 5,890 | 5,970 | 5,880 | 5,940 | +30 | +0.5% | 75,700 |
2019/12/03 | 5,890 | 5,970 | 5,870 | 5,910 | -60 | -1% | 95,200 |
2019/12/02 | 5,930 | 5,980 | 5,910 | 5,970 | +80 | +1.4% | 78,800 |
1351~
1400
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 267,000円 | +21.7% | +999.9% | 0.00% | 12.30倍 | 4.21倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム